{"entity":{"type":"insider","cik":"0001249422","url":"/insider/0001249422","json_url":"/insider/0001249422.json","name":"GALLIKER STEPHEN S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2006-05-22","last":"2014-02-05","span_basis":"filed_date"},"name_variants":[{"name":"GALLIKER STEPHEN S","source":"filing","n_filings":3,"first_seen":"2006-05-22","last_seen":"2014-02-05"}],"transactions":[{"id":6536426,"accession":"0001250853-14-000043","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001250853-14-000043","line_url":"/filing/0001250853-14-000043#line-6","is_derivative":false,"issuer_cik":"0001249422","issuer_name":"Galena Biopharma, Inc.","issuer_ticker":"GALE","issuer_name_source":null,"issuer_url":"/issuer/0001249422","owner_cik":"0001249422","owner_name":"GALLIKER STEPHEN S","owner_display_name":"GALLIKER STEPHEN S","owner_url":"/insider/0001249422","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":4.1768,"price_display":"4.18","price_state":"stated","total_value":1253040.0,"total_display":"1,253,040.00","total_whole":"1,253,040","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-03","filed_date":"2014-02-05","scope":"insider"},{"id":7220649,"accession":"0001209191-10-019337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-019337","line_url":"/filing/0001209191-10-019337#line-1","is_derivative":false,"issuer_cik":"0001249422","issuer_name":"RXI PHARMACEUTICALS CORP","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001249422","owner_cik":"0001249422","owner_name":"GALLIKER STEPHEN S","owner_display_name":"GALLIKER STEPHEN S","owner_url":"/insider/0001249422","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":5.54,"price_display":"5.54","price_state":"stated","total_value":83100.0,"total_display":"83,100.00","total_whole":"83,100","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-26","filed_date":"2010-03-30","scope":"insider"},{"id":3556770,"accession":"0001180955-06-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001180955-06-000021","line_url":"/filing/0001180955-06-000021#line-1","is_derivative":false,"issuer_cik":"0000907562","issuer_name":"DYAX CORP","issuer_ticker":"DYAX","issuer_name_source":null,"issuer_url":"/issuer/0000907562","owner_cik":"0001249422","owner_name":"GALLIKER STEPHEN S","owner_display_name":"GALLIKER STEPHEN S","owner_url":"/insider/0001249422","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.3,"price_display":"3.30","price_state":"stated","total_value":33000.0,"total_display":"33,000.00","total_whole":"33,000","shares_owned_after":63142.0,"shares_owned_after_display":"63,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-19","filed_date":"2006-05-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001390478","name":"Galena Biopharma, Inc.","url":"/issuer/0001390478","role":"Director","n_filings":2,"first_seen":"2010-03-30","last_seen":"2014-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000907562","name":"DYAX CORP","url":"/issuer/0000907562","role":"Officer (EVP and CFO)","n_filings":1,"first_seen":"2006-05-22","last_seen":"2006-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001249422","retrieved_at":"2026-08-24T04:12:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}